Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease
Davide Ramoni, Luca Liberale, Fabrizio Montecucco · 2024
Read Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease by Davide Ramoni, Luca Liberale, Fabrizio Montecucco (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11612858.txt.
Description
Davide Ramoni and co-authors argue, in a 2024 letter, that simple inflammation markers could cheaply flag the fatty liver patients most likely to worsen. The condition, now called metabolic dysfunction-associated fatty liver disease, affects about a quarter of the world's people and is the most common chronic liver problem. Finding it early and judging its course usually needs costly scans or biopsies. The authors build on a study that stressed the need for non-invasive tools.
They survey inflammation-linked markers that also tie into heart and metabolic disorders. Such markers might sort patients by risk and show whether treatment is working, at a fraction of imaging costs. Gaps remain: labs lack shared protocols, and the markers need firmer proof in clinic use. The letter calls for research to settle those questions and unlock a low-cost testing path.
Catalog record
| CREATOR | Davide Ramoni, Luca Liberale, Fabrizio Montecucco |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |